|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tempest Therapeutics, Inc (TPST) |
|
|
$1.06 0.00 (0.00%) as of 4:30 Fri 6/25
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
6,640,000 |
| Market
Cap: |
7.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.06 - $1.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tempest Therapeutics is a biopharmaceutical company, focused on developing treatments for endocrine diseases. Co.'s three product candidates are: Livoletide (AZP-531), which is for the treatment Prader-Willi syndrome, a genetic endocrine disease usually characterized by hyperphagia, or insatiable hunger; nevanimibe (ATR-101), which is a potential treatment for patients with congenital adrenal hyperplasia, a monogenic adrenal disease that requires lifelong treatment with exogenous cortisol, often at high doses; and NK3R antagonist (MLE-301), which is a potential treatment of vasomotor symptoms commonly known as hot flashes and night sweats, in menopausal women.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Dipp Michelle |
President and CEO |
• • • |
2013-11-18 |
4 |
AB |
$8.65 |
$3,460 |
D/D |
400 |
814,257 |
|
- |
|
| Dipp Michelle |
President and CEO |
• • • |
2013-09-30 |
4 |
D |
$9.91 |
$51,770 |
D/D |
(5,224) |
813,857 |
|
- |
|
| Tzianabos Arthur |
Chief Scientific Officer |
• – – |
2013-09-12 |
4 |
B |
$10.32 |
$10,320 |
I/I |
1,000 |
1,000 |
1.99 |
- |
|
| Stock Harald F. |
Director |
– • – |
2013-09-12 |
4 |
B |
$10.64 |
$47,880 |
I/I |
4,500 |
4,500 |
2.1 |
- |
|
| Bleck Christopher A |
Chief Commercial Officer |
• – – |
2013-09-11 |
4 |
B |
$11.15 |
$22,300 |
I/I |
2,000 |
2,000 |
1.99 |
- |
|
| Aldrich Richard |
Director |
– • • |
2013-09-11 |
4 |
B |
$10.54 |
$51,119 |
I/I |
4,850 |
4,850 |
2.25 |
- |
|
| Westphal Christoph H |
Director |
– • • |
2013-09-11 |
4 |
B |
$10.53 |
$51,071 |
I/I |
4,850 |
4,850 |
2.25 |
- |
|
| Dipp Michelle |
President & CEO |
• • • |
2013-06-30 |
4 |
D |
$13.73 |
$71,231 |
D/D |
(5,188) |
819,081 |
|
- |
|
| Dipp Michelle |
President and CEO |
• • • |
2013-03-31 |
4 |
D |
$9.00 |
$52,767 |
D/D |
(5,863) |
824,269 |
|
- |
|
| Capello Jeffrey D |
Director |
– • – |
2013-03-18 |
4 |
B |
$9.00 |
$99,999 |
D/D |
11,111 |
11,111 |
2.39 |
- |
|
| Longwood Fund, L.p. |
10% Owner |
– – • |
2013-03-18 |
4 |
B |
$9.00 |
$3,774,996 |
D/D |
419,444 |
3,720,571 |
2.45 |
- |
|
| Malley Thomas |
Director |
– • – |
2013-03-18 |
4 |
B |
$9.00 |
$450,000 |
D/D |
50,000 |
81,819 |
2.39 |
- |
|
| Dipp Michelle |
President and CEO |
• • • |
2012-12-05 |
4 |
A |
$0.00 |
$0 |
D/D |
128,205 |
830,132 |
|
- |
|
| Malley Thomas |
Director |
– • – |
2012-10-24 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
31,819 |
|
- |
|
| Dipp Michelle |
President and CEO |
• • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,301,127 |
3,301,127 |
|
- |
|
| Aldrich Richard |
Director |
– • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,301,127 |
3,476,608 |
|
- |
|
| Westphal Christoph H |
Director |
– • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
3,301,127 |
3,301,127 |
|
- |
|
| Longwood Fund, L.p. |
10% Owner |
– – • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
3,301,127 |
3,301,127 |
|
- |
|
| Fialkow David P |
Director |
– • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
D/D |
1,090,908 |
22,306 |
|
- |
|
| Simon John G |
Director |
– • – |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
1,090,908 |
1,090,908 |
|
- |
|
| Deer Management Co. Llc |
Director |
– • • |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
2,392,034 |
2,392,034 |
|
- |
|
| Kraus Stephen |
Director |
– • – |
2012-08-13 |
4 |
A |
$0.00 |
$0 |
I/I |
0 |
0 |
|
- |
|
| Tilly Jonathan L |
Director |
– • – |
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
701,927 |
|
- |
|
| Aldrich Richard |
Director |
– • • |
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
175,481 |
|
- |
|
| Aldrich Richard |
Director |
– • • |
2012-06-11 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
526,445 |
|
- |
|
227 Records found
|
|
Page 9 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
